Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers
about
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON studyDoes bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersThe risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy.Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatmentClinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review.Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillanceLong-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.Role of Breast Surgery in BRCA Mutation Carriers.Management of the asymptomatic BRCA mutation carrier.Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testingLong-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers.Managing the breast in patients who test positive for hereditary breast cancer.Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations.Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.Surgical Decision Making in the BRCA-Positive Population: Institutional Experience and Comparison with Recent Literature.Heightened perception of breast cancer risk in young women at risk of familial breast cancer.Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.Study on the psychosocial aspects of risk-reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutation carriers in Japan: a preliminary report.Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.Anticipatory loss and early mastectomy for young female BRCA1/2 mutation carriers.Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers.Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation.Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions.
P2860
Q30896495-13F8CF4A-5FB9-497E-A8A8-746677237399Q34125241-58109A67-0BCD-480B-A072-3AF9EDFAF0C0Q34475484-E2F214FD-0CA4-4E64-87AA-76C76BB8F74EQ34481713-A817C397-A200-47C3-84A6-7B211475E739Q35021170-2CA27207-F002-40A9-9316-C89EFEC6B03AQ35617340-15DC551A-948F-48CC-9165-2AAF0B92B7D9Q35687632-6934454D-C85C-4687-9370-98A10765A877Q35777905-AC720117-10A3-49E1-84C8-788456072EB2Q35815469-6E5197D2-F4C2-4942-8E3A-47FA1F273EB1Q36240959-E2EB5F0B-5B92-4739-BA05-05E510DF5EE0Q36457900-8FA59547-CC96-4F11-80EA-F0555305172DQ36925172-28FDC56C-32B0-40C7-AFB5-11F6D213565BQ37185670-8FA378B6-C850-4F46-9D09-2344CF3B4D48Q37688802-1719D7FF-10F2-4BC9-B630-9991901BC7B5Q37991240-08F3FA7D-4BD6-4E09-BE5C-D1E645AA347EQ38213995-9209B637-2846-4C3F-89EB-6B8283178722Q38599703-15807E13-2A29-4F10-83EB-E2E1F345B4FDQ38676694-C7A96E50-F2B5-45D9-B0EE-FC956E0E0534Q38684207-91BD8FF1-0A35-4FEF-9933-7D2655C16E1BQ38759417-39EFA3BF-186F-41EE-AEEE-1BE11C7EF1B4Q38905495-8C7A45B1-75F7-4F3E-AE99-8DAA35E4CD60Q41035840-42D82A30-66A1-4032-8C2D-9147A3751E5BQ41195564-603D2A26-A96E-41A7-AEAA-E6938082F294Q44400604-03637FE2-D899-4E28-96BE-586F1E48EA48Q44657438-4EAB5A42-F0CB-4B5A-9B1C-C6ABFFF2C6C9Q44696764-52B7BBEC-C88E-434B-BF4E-2AD3FD9D4821Q46971163-D9A57CD9-1376-4E5A-9401-EB5380254E00Q48629272-DBEBD178-6B1C-48F2-9F8A-A59A62713CD4Q51017508-AA1B6211-1D0F-4FBD-800F-BB9AAA86CEBE
P2860
Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers
@ast
Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers
@en
Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers
@nl
type
label
Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers
@ast
Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers
@en
Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers
@nl
prefLabel
Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers
@ast
Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers
@en
Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers
@nl
P2093
P2860
P356
P1476
Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers
@en
P2093
Beth Crawford
John Ziegler
Mary S Beattie
P2860
P356
10.1089/GTMB.2008.0067
P577
2009-02-01T00:00:00Z